ADRM1 Antibody

Code CSB-PA001396HA01HU
Size US$166
Order now
Image
  • Western Blot
    Positive WB detected in: Mouse stomach tissue
    All lanes: ADRM1 antibody at 2.7μg/ml
    Secondary
    Goat polyclonal to rabbit IgG at 1/50000 dilution
    Predicted band size: 43 kDa
    Observed band size: 43 kDa

  • Immunohistochemistry of paraffin-embedded human testis tissue using CSB-PA001396HA01HU at dilution of 1:100

  • Immunofluorescent analysis of MCF-7 cells using CSB-PA001396HA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)

The Latest Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) ADRM1 Polyclonal antibody
Uniprot No.
Target Names
ADRM1
Alternative Names
110 kDa cell membrane glycoprotein antibody; adhesion regulating molecule 1 antibody; Adhesion-regulating molecule 1 antibody; ADRM 1 antibody; Adrm1 antibody; ADRM1_HUMAN antibody; ARM 1 antibody; ARM-1 antibody; ARM1 antibody; Gp110 antibody; hRpn13 antibody; M(r) 110,000 surface antigen antibody; Proteasomal ubiquitin receptor ADRM1 antibody; proteasome regulatory particle non ATPase 13 antibody; Proteasome regulatory particle non-ATPase 13 antibody; Regulatory particle non ATPase 13 antibody; Rpn13 antibody; Rpn13 homolog antibody
Raised in
Rabbit
Species Reactivity
Human, Mouse
Immunogen
Recombinant Human Proteasomal ubiquitin receptor ADRM1 protein (2-407AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The ADRM1 Antibody (Product code: CSB-PA001396HA01HU) is Non-conjugated. For ADRM1 Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA001396HB01HU ADRM1 Antibody, HRP conjugated ELISA
FITC CSB-PA001396HC01HU ADRM1 Antibody, FITC conjugated
Biotin CSB-PA001396HD01HU ADRM1 Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form
Liquid
Tested Applications
ELISA, WB, IHC, IF
Recommended Dilution
Application Recommended Dilution
WB 1:1000-1:5000
IHC 1:20-1:200
IF 1:50-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. Within the complex, functions as a proteasomal ubiquitin receptor. Engages and activates 19S-associated deubiquitinases UCHL5 and PSMD14 during protein degradation. UCHL5 reversibly associate with the 19S regulatory particle whereas PSMD14 is an intrinsic subunit of the proteasome lid subcomplex.
Gene References into Functions
  1. Rpn13-Rpn2 complex structural analysis shows that RA190 targets hRpn13 and Uch37 through parallel mechanisms and at proteasomes, RA190-inactivated Uch37 cannot disassemble hRpn13-bound ubiquitin chains PMID: 28598414
  2. findings indicate that up-regulated ADRM1 was involved in intrahepatic cholangiocarcinoma (ICC) progression and suggest the potential clinical application of ADRM1 inhibitors (e.g., RA190 and KDT-11) for ICC treatment. PMID: 29913454
  3. We show that ADRM1 mRNA overexpression is an early event in high grade serous carcinoma of the ovary. This is associated with TP53 mutation and increased burden of misfolded proteins in carcinomas that likely renders the cancer cells particularly sensitive to RPN13 inhibitors. PMID: 28784174
  4. evidence that the interaction can mediate the association of Rpn13 and SGTA in a cellular context. PMID: 27827410
  5. The structures of proteasome substrate receptor complexes with the shuttle factors that deliver ubiquitinated proteins to proteasomes have been solved, namely human Rpn13 complexed with PLIC2 and Saccharomyces cerevisiae Rpn1 with Rad23. PMID: 27396824
  6. RPN13 binds ubiquitin with an affinity similar to that of other proteasome-associated ubiquitin receptors and that RPN2, ubiquitin, and the deubiquitylase UCH37 bind to RPN13 with independent energetics. PMID: 28442575
  7. regulation of NY-ESO-1 processing by the ubiquitin receptors Rpn10 and Rpn13 as a well as by the standard and immunoproteasome is governed by non-canonical ubiquitination on non-lysine sites. PMID: 26903513
  8. this work implicates hRpn13 and Uch37 in cell cycle progression, providing a rationale for their function in cellular proliferation and for the apoptotic effect of the hRpn13-targeting molecule RA190. PMID: 26907685
  9. the binding of SGTA to Rpn13 enables specific polypeptides to escape proteasomal degradation and/or selectively modulates substrate degradation. PMID: 26169395
  10. Data suggest that ADRM1 is involved in proliferation of acute leukemia cells; expression of ADRM1 is up-regulated in leukemia; knockdown of ADRM1 inhibits cell proliferation at G0/G1 phase of cell cycle but does not affect apoptosis/cell migration. PMID: 25896055
  11. findings implicate Rpn13 in linking parkin to the 26 S proteasome and regulating the clearance of mitochondrial proteins during mitophagy PMID: 25666615
  12. Data show that DEUBAD domain in RPN13 (ADRM1) activates ubiquitin thioesterase L5 (UCH-L5), and the related DEUBAD domain in INO80G (NFRKB) inhibits UCH-L5. PMID: 25702870
  13. Together, our findings suggest that the interaction of Psmd1 with Adrm1 is controlled by SUMOylation in a manner that may alter proteasome composition and function. PMID: 24910440
  14. ADRM1 is a candidate target gene in the chromosome 20q13.33 amplicon that may possibly be linked to development of gastric cancer PMID: 24968865
  15. Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates. PMID: 24811749
  16. Inherent asymmetry in the 26S proteasome is defined by the ubiquitin receptor RPN13. PMID: 24429290
  17. mRNA and protein levels of ADRM1 were increased in hepatocellular carcinoma tissues and was parallel to the metastatic potential PMID: 22576803
  18. hRpn13 modulates the influence of osteoblasts on osteoclasts by controlling the stability of regulatory proteins in osteoblasts. PMID: 22057889
  19. this study provides a possible mechanism of action in ovarian cancer for amplification and overexpression of ADRM1 PMID: 21432940
  20. In tumor cells non-phosphorylated DeltaNp63alpha failed to form protein complexes with Rpn13, allowing the latter to bind and target LKB1 into a proteasome-dependent degradation pathway, modulating cisplatin-induced autophagy. PMID: 21191146
  21. Phosphorylated TP63 induces transcription of RPN13, leading to NOS2 protein degradation PMID: 20959455
  22. Silencing of Adrm1 by RNA interference can significantly suppress proliferation of colorectal cancer cells through inducing apoptosis and arresting the cell cycle. PMID: 20137344
  23. show that Rpn13 is involved in inducible nitric oxide synthase degradation and is required for iNOS interaction with the deubiquitination protein UCH37. PMID: 20634424
  24. results suggest that there is different substrate specificity between S5a and hRpn13 at the level of delivery and S5a may be the major docking site for ERAD substrates. PMID: 20417181
  25. Rpn13 binding to the proteasome scaffolding protein hRpn2/S1 abrogates its interdomain interactions, thus activating hRpn13 for ubiquitin binding. PMID: 20471946
  26. ARM-1 is a cytosolic protein associated with the plasma membrane. However, no cell surface expression of the protein was observed. These results suggest an indirect role of ARM-1 in adhesion rather than a direct role as an adhesion molecule itself.[ARM-1] PMID: 15819879
  27. Adrm1 has a specialised role in proteasome function. Identified Adrm1 as a novel component of the regulatory ATPase complex of the 26 S proteasome PMID: 16815440
  28. Neither Uch37 alone nor the Uch37-Adrm1 or Uch37-Adrm1-S1 complexes can hydrolyse di-ubiquitin efficiently; rather, incorporation into the 19S complex is required to enable processing of polyubiquitin chains. PMID: 16906146
  29. These results indicate that hRpn13 (Adrm1) is essential for the activity of UCH37. PMID: 16990800
  30. In human 26S proteasomes, hRpn13 appears to be important for the binding of UCH37 to the 19S complex and for efficient proteolysis. PMID: 17139257
  31. identification of a new ubiquitin receptor, Rpn13/ARM1, a known component of the proteasome PMID: 18497817
  32. ADRM1 overexpression was the most highly correlated with amplification and is associated with ovarian cancer. PMID: 18615678
  33. Adrm1 is potentially oncogenic and may play an important role in colon tumorigenesis PMID: 19148532
  34. these data suggest that Adrm1, a new Atp6v0d2-interacting protein, plays an important role in osteoclast differentiation, and in particular the fusion of preosteoclasts. PMID: 19818731

Show More

Hide All

Subcellular Location
Cytoplasm. Nucleus.
Protein Families
ADRM1 family
Database Links

HGNC: 15759

OMIM: 610650

KEGG: hsa:11047

STRING: 9606.ENSP00000253003

UniGene: Hs.90107

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
webinars: DT3C facilitates antibody internalization X
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*